Regeneron Pharmaceuticals (REGN) Stock Forecast for 2023 – 2026. Sell or Buy Prediction







Trading Penny Stocks for Profit: Expert Insights and Practical Advice

February 22, 2024 Trading Penny Stocks for Profit: Expert Insights and Practical Advice

For aspiring traders and seasoned investors alike, the enticing appeal of penny stocks can be likened to voyaging across the vast oceans, discovering…
Getting A Kredittkort Norge Approval Isn’t Difficult

February 8, 2024 Getting A Kredittkort Norge Approval Isn’t Difficult

If you meet the conditions, you can open an account for checking in Norway. However, it will be much easier and more convenient…
How to Understand Social Security: 6 Legal & Financial Tips

January 25, 2024 How to Understand Social Security: 6 Legal & Financial Tips

Understanding social security can seem overwhelming, but it’s an important part of financial planning, particularly for retirement. The following 6 legal and financial…
Finding Energy Plans with Billig Strøm Rates

January 10, 2024 Finding Energy Plans with Billig Strøm Rates

It can be overwhelming to decide on the best plan when in a state where electricity is deregulated. The number of providers is…

Regeneron Pharmaceuticals (REGN) Stock Forecast for 2023 – 2026. Sell or Buy?

Updated: March 4, 2024 (05:51)

Sector: Healthcare

The share price of Regeneron Pharmaceuticals, Inc. (REGN) now

Latest session on the 4th of March for
Regeneron Pharmaceuticals, Inc. is negative
Trading Volume: 420115
Open: 982.82 /  High: 985.21 /  Low: 966.22
What analysts predict: $1023.41
52-week High/Low: $998.33 / $684.8

50/200 Day Moving Average: $930.25 / $825.02

This figure corresponds to the Average Price over the previous 50/200 days. For Regeneron Pharmaceuticals stocks, the 50-day moving average is the support level today.

For Regeneron Pharmaceuticals stocks, the 200-day moving average is the support level today.

Are you interested in Regeneron Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Regeneron Pharmaceuticals stock price in 2024, 2025, 2026, 2027, 2028. How much will one Regeneron Pharmaceuticals share be worth in 2024 - 2028?

When should I take profit in Regeneron Pharmaceuticals stock? When should I record a loss on Regeneron Pharmaceuticals stock? What are analysts' forecasts for Regeneron Pharmaceuticals stock? What is the future of Regeneron Pharmaceuticals stock? We forecast Regeneron Pharmaceuticals stock performance using neural networks based on historical data on Regeneron Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Regeneron Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Regeneron Pharmaceuticals shares. This happens once a day.


Historical and forecast chart of Regeneron Pharmaceuticals stock

The chart below shows the historical price of Regeneron Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Regeneron Pharmaceuticals stock price can be found in the table below.

Long-term forecasts by years.

Regeneron Pharmaceuticals, Inc. is an American biotech company headquartered in Eastview, near Tarrytown, New York. The company was founded in 1988. Initially, it focused on neurotrophic factors and their regenerative capabilities (hence the name), and then branched out into the study of both cytokine and tyrosine kinase receptors.

Regeneron Pharmaceuticals daily forecast for a month

Date Target Pes. Opt. Vol., %
Mar 06 1 006.72 980.95 1 027.98 4.79
Mar 07 1 015.42 1 006.65 1 035.24 2.84
Mar 08 993.98 979.66 1 009.88 3.08
Mar 09 967.26 960.76 984.59 2.48
Mar 10 972.21 954.17 997.10 4.50
Mar 11 993.05 970.17 1 000.36 3.11
Mar 12 1 001.63 987.85 1 014.13 2.66
Mar 13 1 014.77 999.19 1 039.78 4.06
Mar 14 993.99 969.18 1 007.67 3.97
Mar 15 963.46 947.12 986.89 4.20
Mar 16 956.98 949.94 968.93 2.00
Mar 17 972.29 959.54 979.14 2.04
Mar 18 983.18 964.94 1 003.32 3.98
Mar 19 999.54 990.27 1 020.33 3.04
Mar 20 998.26 984.21 1 004.65 2.08
Mar 21 1 002.74 980.28 1 026.16 4.68
Mar 22 1 001.13 976.14 1 016.83 4.17
Mar 23 1 026.44 1 019.54 1 049.76 2.96
Mar 24 1 025.46 1 010.03 1 048.75 3.83
Mar 25 1 011.67 990.31 1 021.06 3.11
Mar 26 1 014.59 1 000.63 1 027.57 2.69
Mar 27 985.69 962.35 994.21 3.31
Mar 28 983.48 971.84 995.13 2.40
Mar 29 982.54 964.30 995.75 3.26
Mar 30 995.12 985.24 1 006.58 2.17
Mar 31 1 026.32 1 004.98 1 052.60 4.74
Apr 01 1 023.70 1 013.87 1 034.83 2.07
Apr 02 1 037.13 1 017.88 1 046.42 2.80
Apr 03 1 005.27 994.01 1 022.64 2.88
Apr 04 987.57 968.93 994.84 2.67

Regeneron Pharmaceuticals Daily Price Targets


Regeneron Pharmaceuticals Stock Forecast 03-06-2024.

Forecast target price for 03-06-2024: $1 006.72.
Positive dynamics for Regeneron Pharmaceuticals shares will prevail with possible volatility of 4.575%.
Pessimistic target level: 980.95
Optimistic target level: 1 027.98

Regeneron Pharmaceuticals Stock Forecast 03-07-2024.

Forecast target price for 03-07-2024: $1 015.42.
Positive dynamics for Regeneron Pharmaceuticals shares will prevail with possible volatility of 2.762%.
Pessimistic target level: 1 006.65
Optimistic target level: 1 035.24

Regeneron Pharmaceuticals Stock Forecast 03-08-2024.

Forecast target price for 03-08-2024: $993.98.
Negative dynamics for Regeneron Pharmaceuticals shares will prevail with possible volatility of 2.992%.
Pessimistic target level: 979.66
Optimistic target level: 1 009.88

Regeneron Pharmaceuticals Stock Forecast 03-09-2024.

Forecast target price for 03-09-2024: $967.26.
Negative dynamics for Regeneron Pharmaceuticals shares will prevail with possible volatility of 2.421%.
Pessimistic target level: 960.76
Optimistic target level: 984.59

Regeneron Pharmaceuticals Stock Forecast 03-10-2024.

Forecast target price for 03-10-2024: $972.21.
Positive dynamics for Regeneron Pharmaceuticals shares will prevail with possible volatility of 4.306%.
Pessimistic target level: 954.17
Optimistic target level: 997.10

Regeneron Pharmaceuticals Stock Forecast 03-11-2024.

Forecast target price for 03-11-2024: $993.05.
Positive dynamics for Regeneron Pharmaceuticals shares will prevail with possible volatility of 3.018%.
Pessimistic target level: 970.17
Optimistic target level: 1 000.36

REGN (REGN) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Apr. 950.09 923.59 991.99 6.90
May. 933.85 870.81 959.90 9.28
Jun. 974.19 938.24 1 034.68 9.32
Jul. 989.09 919.66 1 027.37 10.48
Aug. 973.96 915.23 1 012.53 9.61
Sep. 1 031.81 998.38 1 090.32 8.43
Oct. 1 034.60 1 005.73 1 096.05 8.24
Nov. 988.97 945.36 1 017.46 7.09
Dec. 972.06 934.44 1 000.06 6.56

Regeneron Pharmaceuticals forecast for this year


Regeneron Pharmaceuticals Stock Prediction for Apr 2024

An downtrend is forecast for this month with an optimal target price of $950.092. Pessimistic: $923.59. Optimistic: $991.99


Regeneron Pharmaceuticals Stock Prediction for May 2024

An downtrend is forecast for this month with an optimal target price of $933.846. Pessimistic: $870.81. Optimistic: $959.90


Regeneron Pharmaceuticals Stock Prediction for Jun 2024

An uptrend is forecast for this month with an optimal target price of $974.188. Pessimistic: $938.24. Optimistic: $1 034.68


Regeneron Pharmaceuticals Stock Prediction for Jul 2024

An uptrend is forecast for this month with an optimal target price of $989.093. Pessimistic: $919.66. Optimistic: $1 027.37


Regeneron Pharmaceuticals Stock Prediction for Aug 2024

An downtrend is forecast for this month with an optimal target price of $973.96. Pessimistic: $915.23. Optimistic: $1 012.53


Regeneron Pharmaceuticals Stock Prediction for Sep 2024

An uptrend is forecast for this month with an optimal target price of $1031.81. Pessimistic: $998.38. Optimistic: $1 090.32


Regeneron Pharmaceuticals Stock Prediction for Oct 2024

An uptrend is forecast for this month with an optimal target price of $1034.6. Pessimistic: $1 005.73. Optimistic: $1 096.05


Regeneron Pharmaceuticals Stock Prediction for Nov 2024

An downtrend is forecast for this month with an optimal target price of $988.973. Pessimistic: $945.36. Optimistic: $1 017.46


Regeneron Pharmaceuticals Stock Prediction for Dec 2024

An downtrend is forecast for this month with an optimal target price of $972.061. Pessimistic: $934.44. Optimistic: $1 000.06



Regeneron Pharmaceuticals (REGN) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 986.93 949.63 1 011.80 6.14
Feb 906.10 853.91 960.74 11.12
Mar 899.58 874.48 927.92 5.76
Apr 914.96 857.32 934.73 8.28
May 919.08 867.80 947.20 8.38
Jun 945.55 916.62 1 005.12 8.81
Jul 909.81 854.95 946.66 9.69
Aug 874.60 849.41 913.96 7.06
Sep 911.59 877.96 939.49 6.55
Oct 911.59 887.80 959.18 7.44
Nov 836.93 809.07 892.67 9.37
Dec 815.84 787.21 865.04 9.00

Regeneron Pharmaceuticals (REGN) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 815.84 799.69 847.42 5.63
Feb 844.48 790.52 899.96 12.16
Mar 843.72 787.53 868.02 9.27
Apr 820.18 769.99 849.71 9.38
May 785.49 749.43 830.73 9.79
Jun 781.25 757.34 837.49 9.57
Jul 715.15 686.83 738.32 6.97
Aug 732.53 687.04 745.72 7.87
Sep 704.18 669.96 724.46 7.52
Oct 695.94 674.02 719.12 6.27
Nov 680.28 657.02 721.92 8.99
Dec 670.49 625.23 699.45 10.61

Regeneron Pharmaceuticals (REGN) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 683.76 640.07 718.84 10.96
Feb 672.69 644.84 718.09 10.20
Mar 680.56 650.54 729.56 10.83
Apr 654.22 635.38 694.85 8.56
May 631.84 589.20 666.53 11.60
Jun 632.98 590.83 677.42 12.78
Jul 623.30 607.03 644.61 5.83
Aug 622.74 579.02 654.12 11.48
Sep 600.32 583.03 632.74 7.86
Oct 585.73 556.21 623.16 10.74
Nov 613.67 592.13 638.52 7.27
Dec 611.46 599.35 646.13 7.24

Regeneron Pharmaceuticals (REGN) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 597.70 571.88 629.44 9.14
Feb 634.82 614.82 647.96 5.11
Mar 611.97 578.37 634.55 8.85
Apr 640.61 625.62 675.78 7.42
May 637.72 624.52 675.60 7.56
Jun 687.08 641.94 724.19 11.36
Jul 687.70 674.70 703.79 4.13
Aug 701.94 655.19 731.63 10.45
Sep 714.57 679.20 749.94 9.43
Oct 717.79 703.58 761.72 7.63
Nov 697.76 651.92 747.37 12.77
Dec 758.68 706.78 810.57 12.80

Regeneron Pharmaceuticals information and performance

Regeneron Pharmaceuticals Address

777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, US

Market Capitalization: 107 876 286 000 $

Market capitalization of the Regeneron Pharmaceuticals, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of REGN shares in the company outstanding by the market price of one share.

EBITDA: 4 654 200 000 $

EBITDA of Regeneron Pharmaceuticals is earnings before interest, income tax and depreciation of assets.

PE Ratio: 28.25

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 2.002

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 34.79

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: -0.029
Quarterly Revenue Growth YOY: 0.006
Trailing PE: 28.25

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 21.93

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 7.6

Enterprise Value (EV) /Revenue

EV To EBITDA: 21.25

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 107944000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.